Schedule of Summarizes Information About Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands		6 Months Ended
		Jun. 30, 2021
2014 Long Term Incentive Equity Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Stock Options Outstanding, Beginning Balance		6,798,529
Weighted Average Exercise Price, Beginning Balance		$ 2.55
Number of Stock Options, Granted	[1]	2,355,000
Weighted Average Exercise Price, Granted	[1]	$ 4.59
Number of Stock Option, Exercised		(120,832)
Weighted Average Exercise Price, Exercised		$ 1.08
Number of Stock Option, Forfeited		(25,833)
Weighted Average Exercise Price, Forfeited		$ 2.44
Number of Stock Options Outstanding, Ending Balance		9,006,864
Weighted Average Exercise Price, Ending Balance		$ 3.11
Remaining Contractual Term (Years) stock options, Ending Balance		6 years 10 months 24 days
Intrinsic Value of Outstanding Stock Option, Ending Balance	[2]	$ 29,843
Number of Stock Options Vested and exercisable stock options		5,972,706
Weighted Average Exercise Price, Vested and exercisable stock options		$ 2.89
Remaining Contractual Term (Years), Vested and exercisable stock options		5 years 8 months 12 days
Intrinsic Value of Vested and Exercisable Stock Option, Ending Balance	[2]	$ 21,289
Number of Stock Option, Exercised		120,832
Number of Stock Option, Forfeited		25,833
2018 Long Term Incentive Equity Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Stock Options Outstanding, Beginning Balance		991,667
Weighted Average Exercise Price, Beginning Balance		$ 0.86
Number of Stock Options, Granted	[3]
Weighted Average Exercise Price, Granted	[3]
Number of Stock Option, Exercised
Weighted Average Exercise Price, Exercised
Number of Stock Option, Forfeited
Weighted Average Exercise Price, Forfeited
Number of Stock Options Outstanding, Ending Balance		991,667
Weighted Average Exercise Price, Ending Balance		$ 0.85
Remaining Contractual Term (Years) stock options, Ending Balance		7 years 6 months
Number of Stock Options Vested and exercisable stock options		876,666
Weighted Average Exercise Price, Vested and exercisable stock options		$ 0.83
Remaining Contractual Term (Years), Vested and exercisable stock options		7 years 4 months 24 days
Remaining Contractual Term (Years) stock options, Beginning		8 years
Number of Stock Option, Exercised
Number of Stock Option, Forfeited

[1] Stock options granted under the PAVmed Inc. 2014 Equity Plan generally vest ratably over twelve quarters, with the vesting commencing with the grant date quarter, and have a ten-year contractual term from date-of-grant.

[2] The intrinsic value is computed as the difference between the quoted price of the PAVmed Inc. common stock on each of June 30, 2021 and December 31, 2020 and the exercise price of the underlying PAVmed Inc. stock options, to the extent such quoted price is greater than the exercise price.

[3] Stock options granted under the Lucid Diagnostics Inc. 2018 Equity Plan generally vest ratably over twelve quarters, with the vesting commencing with the grant date quarter, and have a ten-year contractual term from date-of-grant.